@article{article_1654570, title={Letter to Editor for Prognostic Value of Systemic Immune-Inflammatory Index in Hospitalized Adolescent COVID-19 Patients}, journal={Genel Tıp Dergisi}, volume={35}, pages={793–795}, year={2025}, DOI={10.54005/geneltip.1654570}, author={Uzun, Nedim}, keywords={Adölesan, COVID-19, Prognoz, sistemik immün-inflamatuvar indeks}, abstract={The study by Çağlar et al., published in your General Medicine Journal (Volume 35/Issue 1, February, pp. 123-128), explores the prognostic role of the Systemic Immune-Inflammation Index (SII) in adolescent COVID-19 patients and its effectiveness in predicting intensive care unit (ICU) admission risk compared to other biomarkers. While the study provides valuable insights into the clinical significance of SII in adolescents, it also has methodological and interpretative limitations. The research highlights SII’s potential as a simple, cost-effective biomarker for predicting ICU admission risk (AUC: 0.768, p <0.001), with its calculation based on neutrophil, lymphocyte, and platelet counts aligning well with routine clinical practices. However, the small sample size of ICU-admitted patients (n=14) and the retrospective design limit the generalizability of the findings. Factors such as obesity, time of admission, and SARS-CoV-2 variants were not analyzed, which could influence prognosis. Future multicenter, prospective studies with larger sample sizes and longitudinal data are needed to validate these results and explore SII’s dynamic changes during treatment. Despite these limitations, the study makes a significant contribution by demonstrating SII’s prognostic value, not only in COVID-19 but also in other conditions like acute cholecystitis and testicular torsion, suggesting its broader clinical utility for early risk stratification and resource optimization in adolescent patients.}, number={4}, publisher={Selçuk Üniversitesi}, organization={The article was not supported by any institution.}